Although demonstration of overexpression of p16Ink4a serves as a surrogate marker for a transforming infection with HPV-high-risk genotypes in cervical cancer [4], the largest up to date cohort study revealed that p16Ink4a is not a substitute marker for (hr) HPV-DNA in vSCC [5]. The gene discussed is CDKN2A; the disease is cervical cancer.